[HTML][HTML] Low-dose amiodarone is safe: a systematic review and meta-analysis
R Chokesuwattanaskul, N Shah… - The Journal of …, 2020 - ncbi.nlm.nih.gov
… In conclusion, very-low-dose amiodarone displays a low incidence of … -dose amiodarone
as an average maintenance dose of 200 mg/day or less. Significant side effects of amiodarone …
as an average maintenance dose of 200 mg/day or less. Significant side effects of amiodarone …
Superoxide dismutase 2 Val16Ala polymorphism is associated with amiodarone-associated liver injury
B Radmanovic, J Jovanovic, N Djordjevic… - Experimental and …, 2022 - sciendo.com
… Patients taking amiodarone and having liver injury were mostly carriers of Val/Val (TT) genotype
(13 … with amiodarone-associated liver injury as compared to patients on amiodarone not …
(13 … with amiodarone-associated liver injury as compared to patients on amiodarone not …
[HTML][HTML] Amiodarone
JB Florek, A Lucas, D Girzadas - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
… However, in rare cases, toxicity can advance to end-stage liver disease and cirrhosis.
Furthermore, IV administration of amiodarone may induce acute liver injury within a day of infusion. …
Furthermore, IV administration of amiodarone may induce acute liver injury within a day of infusion. …
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline
R Aller, C Fernandez-Rodriguez, O Lo Iacono… - … y Hepatología (English …, 2018 - Elsevier
… It is estimated that only 2% of liver disease resulting from … directly cause steatosis and
phospholipidosis (amiodarone, … precipitate or aggravate fatty liver disease (tamoxifen, raloxifene, …
phospholipidosis (amiodarone, … precipitate or aggravate fatty liver disease (tamoxifen, raloxifene, …
[HTML][HTML] Amiodarone-induced hepatotoxicity—quantitative measurement of iodine density in the liver using dual-energy computed tomography: Three case reports
HJ Lv, HW Zhao - World Journal of Clinical Cases, 2020 - ncbi.nlm.nih.gov
… He had no apparent history of liver disease. He reported no nausea, vomiting, or diarrhea.
He had no history of smoking-related chronic obstructive pulmonary disease. …
He had no history of smoking-related chronic obstructive pulmonary disease. …
The aftermath of amiodarone therapy: Hyperammonemia and encephalopathy
T Waguespack, BT Cutshall, C Brooks - The Nurse Practitioner, 2022 - journals.lww.com
… likely because he had already developed some hepatic cirrhosis, whereas our patient had
no cirrhosis on imaging. FW had also been taking amiodarone for a shorter period of time, …
no cirrhosis on imaging. FW had also been taking amiodarone for a shorter period of time, …
Detailed molecular mechanisms involved in drug-induced non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: An update
… administration of amiodarone and perhexiline can induce symptomatic liver disease in a
small … Moreover, after acute amiodarone administration, intracytoplasmic lamellar bodies were …
small … Moreover, after acute amiodarone administration, intracytoplasmic lamellar bodies were …
[HTML][HTML] Drug-induced fatty liver disease: Pathogenesis and treatment
… confirmed the role of amiodarone in the induction of liver cirrhosis, with possible … amiodarone
has been suggested by numerous researchers.30,31,33 Most drugs capable of causing …
has been suggested by numerous researchers.30,31,33 Most drugs capable of causing …
Key CT and MRI findings of drug-associated hepatobiliary and pancreatic disorders
S Ichikawa, S Goshima - Japanese Journal of Radiology, 2024 - Springer
… causes of liver disease. Various … caused by amiodarone accumulation in the liver as it
contains two iodine atoms that account for approximately 40% of its molecular weight. Amiodarone …
contains two iodine atoms that account for approximately 40% of its molecular weight. Amiodarone …
… Derived from Human Mesenchymal Stem Cells Induces Hepatoprotective Effects in Models of Idiosyncratic Drug-Induced Liver Injury Caused by Amiodarone or …
… DILI, such as underlying chronic liver disease, and alcohol intake [5]. Several studies have
demonstrated that patients with nonalcoholic fatty liver disease (NAFLD) have impaired liver …
demonstrated that patients with nonalcoholic fatty liver disease (NAFLD) have impaired liver …